Abstract
The aim of this study was to investigate chitosan/siRNA complexes formulated with various chitosan salts (CS) including chitosan aspartate (CS-Asp), chitosan glutamate (CS-Glu), chitosan acetate (CS-Ac), and chitosan hydrochloride (CS-HCl) for in vitro siRNA delivery into stable and constitutive enhanced green fluorescent protein (EGFP)-expressing HeLa cells. The CS/siRNA complexes were characterized by 2% agarose gel electrophoresis and investigated for their transfection efficiency in stable and constitutive EGFP-expressing HeLa cells. The cytotoxicity of the complexes was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. The formation of complexes CS/siRNA is mainly dependent on the weight ratio, whereas salt form and molecular weight has less effect. The particle sizes of the complete complexes were in the range of 270–373 nm except the complete complex of CS-Ac, with a slightly positive charge of less than 2 mV. The ability of CS to transfer functionally active siRNA into cell culture is mainly dependent on the weight ratio and molecular weight of CS whereas salt form of CS has less effect. The high gene-silencing efficiency was observed with low MW of CS (20 kDa) and high weight ratio of 32. Over 80% average cell viabilities were observed for CS/siRNA complexes in all weight ratios comparison to untreated cells. This study suggests CS salts have the potential to be used as safe siRNA delivery vectors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sharp PA. RNA interference. Genes Dev. 2001;15:485–90.
Lee M, Nah JW, Kwon Y, Koh JJ, Ko KS, Kim SW. Water-soluble and low molecular weight chitosan-based plasmid DNA delivery. Pharm Res. 2001;18:427–31.
Ishii T, Okahata Y, Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim Biophys Acta. 2001;1514:51–64.
Weecharangsan W, Opanasopit P, Ngawhirunpat T, Rojanarata T, Apirakaramwong A. Chitosan lactate as a nonviral gene delivery vector in COS-1 cells. AAPS PharmSciTech. 2006;7:E1–6.
Zhao X, Yu SB, Wu FL, Mao ZB, Yu CL. Transfection of primary chondrocytes using chitosan-pEEGFP nanoparticles. J Control Release. 2006;112:223–8.
MacLaughlin FC, Mumper RJ, Wang J, Tagliaferri JM, Gill I, HinCHyiffe M, et al. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Control Release. 1998;56:259–72.
Liu X, Howard KA, Dong M, Andersen MO, Rahbek UL, Johnsen MG, et al. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials. 2007;28:1280–8.
Pille JY, Li H, Blot E, Bertrand JR, Pritchard LL, Opolon P, et al. Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer. Hum Gene Ther. 2006;17:1019–26.
Katas H, Alpar HO. Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release. 2006;115:216–25.
Howard KA, Rahbek UL, Liu X, Damgaard CK, Glud SZ, Andersen MO, et al. RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol Ther. 2006;14:476–84.
Andersen MO, Howard KA, Paludan SR, Besenbacher F, Kjems J. Delivery of siRNA from lyophilized polymeric surfaces. Biomaterials. 2007;29:506–12.
Duan Y, Guan X, Ge J, Quan D, Zhou Y, Ye H, et al. Cationic nano-copolymers mediated IKKbeta targeting siRNA inhibit the proliferation of human Tenon’s capsule fibroblasts in vitro. Mol Vis. 2008;14:2616–28.
Caplen NJ, Parrish S, Iman F, Fire A, Morgan RA. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. PNAS. 2001;98:9742–7.
Rojanarata T, Opanasopit P, Techaapornkul S, Ngawhirunpat T, Ruktanonchai U. Chitosan–thiamine pyrophosphate as a novel carrier for siRNA delivery. Pharm Res. 2008;25:2807–14.
Smith MD, Barbenel JC, Courtney JM, Grant MH. Novel quantitative methods for the determination of biomaterial cytotoxicity. Int J Artif Organs. 1992;15:191–4.
Weecharangsan W, Opanasopit P, Ngawhirunpat T, Apirakaramwong A, Rojanarata T, Ruktanonchai U, et al. Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells. Int J Pharm. 2008;348:161–8.
Thanou M, Florea BI, Geldof M, Junginger HE, Borchard G. Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials. 2002;23:153–9.
Corsi K, Chellat F, Yahia L, Fernandes JC. MesenCHymal stem cells, MG 63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials. 2003;24:1255–64.
Wang SL, Yao HH, Guo LL, Dong L, Li SG, Gu YP, et al. Selection of optimal sites for TGFB1 gene silencing by chitosan-TPP nanoparticle-mediated delivery of shRNA. Cancer Genet Cytogenet. 2009;190:8–14.
Koping-Hoggard M, Varum KM, Issa M, Danielsen S, Christensen BE, Stokke BT, et al. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther. 2004;11:1441–52.
Acknowledgments
The authors wish to thank the National Center for Genetic Engineering and Biotechnology (BIOTEC) Thailand, Commission of Higher Education (Thailand), The Thailand Research Funds, and National Research Council of Thailand for financial support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Techaarpornkul, S., Wongkupasert, S., Opanasopit, P. et al. Chitosan-Mediated siRNA Delivery In Vitro: Effect of Polymer Molecular Weight, Concentration and Salt Forms. AAPS PharmSciTech 11, 64–72 (2010). https://doi.org/10.1208/s12249-009-9355-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-009-9355-6